Wells Fargo’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-61
| Closed | -$123 | – | 7262 |
|
|
2024
Q3 | $123 | Hold |
61
| – | – | ﹤0.01% | 6261 |
|
|
2024
Q2 | $101 | Sell |
61
-17
| -22% | -$45 | ﹤0.01% | 6252 |
|
|
2024
Q1 | $471 | Buy |
78
+1
| +1% | +$7 | ﹤0.01% | 6292 |
|
|
2023
Q4 | $540 | Sell |
77
-33
| -30% | -$256 | ﹤0.01% | 6364 |
|
|
2023
Q3 | $962 | Hold |
110
| – | – | ﹤0.01% | 6213 |
|
|
2023
Q2 | $1.29K | Hold |
110
| – | – | ﹤0.01% | 6276 |
|
|
2023
Q1 | $1.88K | Buy |
110
+3
| +3% | +$65 | ﹤0.01% | 6241 |
|
|
2022
Q4 | $2.81K | Sell |
107
-1,057
| -91% | -$50.2K | ﹤0.01% | 5923 |
|
|
2022
Q3 | $119K | Buy |
1,164
+297
| +34% | +$40.2K | ﹤0.01% | 4519 |
|
|
2022
Q2 | $123K | Buy |
867
+781
| +908% | +$109K | ﹤0.01% | 4530 |
|
|
2022
Q1 | $14K | Buy |
86
+60
| +231% | +$9.69K | ﹤0.01% | 6161 |
|
|
2021
Q4 | $5K | Sell |
26
-132
| -84% | -$25.5K | ﹤0.01% | 6716 |
|
|
2021
Q3 | $30K | Buy |
158
+1
| +0.6% | +$212 | ﹤0.01% | 5824 |
|
|
2021
Q2 | $38K | Buy |
157
+38
| +32% | +$10.4K | ﹤0.01% | 5667 |
|
|
2021
Q1 | $40K | Sell |
119
-534
| -82% | -$217K | ﹤0.01% | 5919 |
|
|
2020
Q4 | $234K | Buy |
653
+558
| +587% | +$215K | ﹤0.01% | 4999 |
|
|
2020
Q3 | $43K | Sell |
95
-62
| -39% | -$17.5K | ﹤0.01% | 5568 |
|
|
2020
Q2 | $22K | Hold |
157
| – | – | ﹤0.01% | 5680 |
|
|
2020
Q1 | $15K | Sell |
157
-159
| -50% | -$18.9K | ﹤0.01% | 5673 |
|
|
2019
Q4 | $42K | Buy |
+316
| New | +$40.5K | ﹤0.01% | 5569 |
|
Other funds holding TFFP
Wells Fargo's TFFP Position: Q4 2024 in Review
Wells Fargo sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 61 shares — an estimated $123 sold.
Wells Fargo first reported a position in TFFP in Q4 2019 and held it in 20 quarters. The position peaked at $234K in Q4 2020. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- Wells Fargo reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Wells Fargo sold 61 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $123.
- Wells Fargo first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 20 quarters.
- Wells Fargo's TFF Pharmaceuticals, Inc. Common Stock position peaked at $234K in Q4 2020.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.